Company: BIVIW
Filing Date: 2025-09-25
Form Type: DEF 14A
Source: 0001520138-25-000287
Chunk: 34

Company: BIOVIE INC.
Filing Date: 2025-09-25
Form: DEF 14A
Chunk 34
---
 of common stock, all of which are exercisable within 60 days of September 22, 2025.                                                                                                                                                                                                                                                                                     |
| (5) | Includes options to purchase 3,309 shares of common stock and 855 RSUs, all of which are exercisable within 60 days of September 22, 2025.                                                                                                                                                                                                                                                                         |
| (6) | Includes options to purchase 10,457 shares of common stock, which are exercisable within 60 days of September 22, 2025. 134 shares of common stock held of record by Sherman Children’s Trust Brian Krisber, Trustee. All shares of common stock, warrants and options are deemed to be beneficially owned or controlled by Michael Sherman.                                                                       |

| -24- |

<div align='center'>CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS</div>

There have been no transactions since July 1, 2024 to which we have been
a party in which the amount involved exceeded or will exceed the lesser of (i) $120,000 and (ii) one percent (1%) of the average of our
total assets at year-end for the prior two fiscal years, and in which any of our directors, executive officers or beneficial owners of
more than 5% of our capital stock or any member of the immediate family of any of the foregoing persons had or will have a direct or indirect
material interest.

Review and Approval of Transactions with Related Persons

Either the Audit Committee or the Board of Directors approves all related
party transactions. The procedure for the review, approval or ratification of related party transactions involves discussing the proposed
transaction with management, discussing the proposed transaction with the external auditors, reviewing financial statements and related
disclosures, and reviewing the details of major deals and transactions to ensure that they do not involve related party transactions.
Members of management have been informed and understand that they are to bring related party transactions to the Audit Committee or the
Board of Directors for pre-approval. These policies and procedures are evidenced in the Audit Committee charter and our code of ethics.

| -25- |

<div align='center'>REPORT OF THE AUDIT COMMITTEE</div>

As more fully described in its Charter, the Audit Committee assists the
Board of Directors in its oversight of BioVie’s corporate accounting and financial reporting process and interacts directly with
and evaluates the performance of BioVie’s independent registered public accounting firm.

In the performance of its oversight function, the Audit Committee has